THE UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER and Tempus, a health-tech company focused on personalizing cancer care, and have partnered to bring MI-ONCOSEQ to patients and healthcare providers across the country who are seeking the high quality data and analyses necessary to personalize treatment for their patients. The MI-ONCOSEQ panel was developed at the University...
Richard Pazdur, FDA’s top oncologist who last week received a battlefield promotion to the role of director of the FDA Center for Drug Evaluation and Research, is described as a stabilizing figure respected by major patient groups, oncology professional societies, and the industry.
